Actualités
Actualités de l'industrie pharmaceutique, analyses de marché, rapports de recherche et mises à jour réglementaires
Derniers articles
Actualités quotidiennes
22 mai 2026•3 min de lecture
WHO Calls for Greater Transparency in Pharmaceutical Pricing
The World Health Organization urges member states to adopt standardized frameworks for medicine pricing disclosure to improve market access globally.
Actualités quotidiennes
21 mai 2026•3 min de lecture
Pfizer Expands API Manufacturing Capacity in Singapore
Pfizer announces a $400M investment to expand active pharmaceutical ingredient production capabilities at its Singapore facility.
Actualités quotidiennes
20 mai 2026•3 min de lecture
Global Pharma Market Expected to Hit $1.9 Trillion by 2027
New industry forecasts project the global pharmaceutical market will surpass $1.9 trillion by 2027, driven by biologics growth and expanding emerging markets.
Actualités réglementaires
18 mai 2026•3 min de lecture
FDA Releases Updated Guidance on Continuous Manufacturing for Drug Substances
The US FDA has issued new draft guidance clarifying regulatory expectations for continuous manufacturing processes in drug substance production.
Analyse de marché
17 mai 2026•3 min de lecture
Biosimilars Market: Growth Drivers and Competitive Dynamics in 2025
An in-depth look at how biosimilar adoption is reshaping pharmaceutical pricing, supply chains, and competitive strategies across major markets.
Actualités réglementaires
16 mai 2026•3 min de lecture
EMA Updates GMP Requirements for Advanced Therapy Medicinal Products
The European Medicines Agency has published revised GMP guidelines for ATMPs including gene therapies, cell therapies, and tissue-engineered products.
Analyse de marché
15 mai 2026•3 min de lecture
Contract Manufacturing in Asia Pacific: Strategic Opportunities for 2025-2027
Asia-Pacific CDMO capacity is expanding rapidly. We analyze where the highest-value opportunities lie for pharma companies seeking manufacturing partners.
Actualités réglementaires
13 mai 2026•3 min de lecture
ICH Q12 Implementation: Post-Approval Change Management Protocols
A practical overview of how pharmaceutical manufacturers are implementing ICH Q12 lifecycle management principles into their post-approval change management workflows.
Recherches & Rapports
12 mai 2026•3 min de lecture
State of Pharmaceutical Supply Chain Resilience 2025
A comprehensive analysis of supply chain vulnerabilities, risk mitigation strategies, and technology adoption trends across global pharmaceutical supply networks.